Science Explorer Back to mapMap
Discussion
Company · New London · United States

Lifepharms (United States)

ROR OpenAlex
Research works
12
▼ 100% vs 2018-21
Citations
1
0.1 per fractional work
Top-10% rate
0.4%
all institutions 10.0%
Open access
25%
world 40%
International
67%
world 18%
Lifepharms (United States)

Not ranked overall: Lifepharms (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Lifepharms (United States) work in?

In all years, 54% of research at Lifepharms (United States) is in Health Sciences, 38% in Life Sciences. Its largest fields are Medicine (44%), Immunology and Microbiology (14%), Biochemistry, Genetics and Molecular Biology (13%). It does 1.6× the world's share of Health Sciences.

Health Sciences: 7 fractional works · 54.2% of its workMedicine: 5 fractional works · 43.7% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 8.5% of its workPhysiology: 1 fractional works · 6.8% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 5.9% of its workEpidemiology: 0 fractional works · 3.6% of its workPulmonary and Respiratory Medicine: 0 fractional works · 3.4% of its workSurgery: 0 fractional works · 2.7% of its workInfectious Diseases: 0 fractional works · 2.6% of its workHematology: 0 fractional works · 1.4% of its workImmunology and Allergy: 0 fractional works · 1.4% of its workNeurology: 0 fractional works · 1.4% of its workPathology and Forensic Medicine: 0 fractional works · 1.4% of its workRehabilitation: 0 fractional works · 1.4% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 1.1% of its workGastroenterology: 0 fractional works · 0.9% of its workPharmacology: 0 fractional works · 0.9% of its workGenetics: 0 fractional works · 0.3% of its workNursing: 1 fractional works · 5.5% of its workNutrition and Dietetics: 1 fractional works · 5.5% of its workVeterinary: 0 fractional works · 3.6% of its workSmall Animals: 0 fractional works · 3.6% of its workHealth Professions: 0 fractional works · 1.4% of its workGeneral Health Professions: 0 fractional works · 1.4% of its workLife Sciences: 5 fractional works · 37.6% of its workImmunology and Microbiology: 2 fractional works · 13.5% of its workImmunology: 1 fractional works · 8.0% of its workMicrobiology: 0 fractional works · 2.7% of its workVirology: 0 fractional works · 2.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 13.2% of its workGenetics: 1 fractional works · 4.8% of its workMolecular Biology: 1 fractional works · 4.3% of its workCell Biology: 0 fractional works · 3.4% of its workEndocrinology: 0 fractional works · 0.6% of its workAgricultural and Biological Sciences: 1 fractional works · 5.9% of its workAnimal Science and Zoology: 0 fractional works · 2.0% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 2.0% of its workInsect Science: 0 fractional works · 0.9% of its workPlant Science: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 1 fractional works · 5.0% of its workEndocrine and Autonomic Systems: 0 fractional works · 4.1% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.9% of its workSocial Sciences: 1 fractional works · 6.9% of its workPsychology: 0 fractional works · 2.7% of its workClinical Psychology: 0 fractional works · 1.4% of its workSocial Psychology: 0 fractional works · 1.4% of its workDecision Sciences: 0 fractional works · 1.4% of its workManagement Science and Operations Research: 0 fractional works · 1.4% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.4% of its workGeneral Economics, Econometrics and Finance: 0 fractional works · 1.4% of its workSocial Sciences: 0 fractional works · 1.4% of its workPolitical Science and International Relations: 0 fractional works · 1.4% of its workPhysical Sciences: 0 fractional works · 1.4% of its workEnvironmental Science: 0 fractional works · 1.4% of its workEcology: 0 fractional works · 1.4% of its workALL ITS WORKLifepharms(United States)12fractional works, all years
Life Sciences38%Physical Sciences1%Health Sciences54%Social Sciences7%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 13 fields, with their numbers
    1. Medicine543.7%
    2. Nursing15.5%
    3. Veterinary03.6%
    4. Health Professions01.4%
    1. Immunology and Microbiology213.5%
    2. Biochemistry, Genetics and Molecular Biology213.2%
    3. Agricultural and Biological Sciences15.9%
    4. Neuroscience15.0%
    1. Psychology02.7%
    2. Decision Sciences01.4%
    3. Economics, Econometrics and Finance01.4%
    4. Social Sciences01.4%
    1. Environmental Science01.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

    What are the most cited papers from Lifepharms (United States)?

    The most cited paper from Lifepharms (United States) is "Vitamin C in human nutrition" (Henriette Frikke‐Schmidt, Pernille Tveden‐Nyborg, Jens Lykkesfeldt, 2011), with 1 citations. Next come "Spontaneous bleeds in the elbows of F8-/- rats cause development of blood-induced joint disease closely resembling human hemophilic arthropathy" (1) and "SSI 2013 Abstract Submission Innate Immunity" (1).

    Most cited papers
    #PaperReleasedCitations
    1 Vitamin C in human nutrition Henriette Frikke‐Schmidt, Pernille Tveden‐Nyborg, Jens Lykkesfeldt · Research at the University of Copenhagen (University of Copenhagen) Book chapter 2011 1
    2 Spontaneous bleeds in the elbows of F8-/- rats cause development of blood-induced joint disease closely resembling human hemophilic arthropathy Anders Popp Thyme, Kåre Kryger Vøls, Kristine Rothaus Christensen et al. · Research at the University of Copenhagen (University of Copenhagen) 2016 1
    3 SSI 2013 Abstract Submission Innate Immunity Sara Marie Atkinson, Mette Thorn, Pernille Autzen Usher et al. · Scandinavian Journal of Immunology Open access 26 Mar 2013 1
    4 Vitaminer til hjernen Pernille Tveden-Nyborg, Jens Lykkesfeldt · Research at the University of Copenhagen (University of Copenhagen) 2016 0
    5 Efficacy of Elimination of Pasteurella pneumotropica from a Mouse Specific Pathogen-Free Barrier Breeding Unit through Treatment with Enrofloxacin Grete Østergaard, Stefania Embla Arnorsdottir, Camilla Schumacher-Petersen et al. · Research at the University of Copenhagen (University of Copenhagen) 2010 0
    All 36 most cited papers, with filters and sorting

    Which research topics does Lifepharms (United States) publish most on?

    By volume: Vitamin C and Antioxidants Research, Cardiovascular Conditions and Treatments, Diet and metabolism studies and Inflammatory Bowel Disease.

    Vitamin C and Antioxidants Research: 1 fractional worksCardiovascular Conditions and Treatments: 1 fractional worksDiet and metabolism studies: 0 fractional worksInflammatory Bowel Disease: 0 fractional worksGut microbiota and health: 0 fractional worksZebrafish Biomedical Research Applications: 0 fractional worksRabies epidemiology and …0Rabies epidemiology and control: 0 fractional worksCardiovascular Disease and Adiposity: 0 fractional worksImmune Response and Inflammation: 0 fractional worksMicrobial infections and…0Microbial infections and disease research: 0 fractional works
    Nutrition and DieteticsRadiology, Nuclear Medicine and ImagingPhysiologyGenetics6 others

    Area is fractional works; colour is the subfield each topic belongs to.

    1. 1 Vitamin C and Antioxidants Research Nutrition and Dietetics 1 works
    2. 2 Cardiovascular Conditions and Treatments Radiology, Nuclear Medicine and Imaging 1 works
    3. 3 Diet and metabolism studies Physiology 0 works
    4. 4 Inflammatory Bowel Disease Genetics 0 works
    5. 5 Gut microbiota and health Molecular Biology 0 works
    6. 6 Zebrafish Biomedical Research Applications Cell Biology 0 works
    7. 7 Rabies epidemiology and control Virology 0 works
    8. 8 Cardiovascular Disease and Adiposity Cardiology and Cardiovascular Medicine 0 works
    9. 9 Immune Response and Inflammation Immunology 0 works
    10. 10 Microbial infections and disease research Microbiology 0 works

    How open and international is its research?

    Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

    openly available24.7%not open75.3%

    World: 40% of research is openly available.

    with international co-authors67.2%domestic only32.8%

    World: 18% is written across borders.

    How has Lifepharms (United States)'s research output changed?

    Output in 2022-2025 was 100% lower than in 2018-2021.

    2015
    grewheldshrank

    The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

    Its share of all research

    Growing output can still be a shrinking share: all of science grows. This is Lifepharms (United States) as a percentage of every work published that year, 0.0000033% in 2018.

    0.000050%0.00010%Lifepharms (United States)0.000022% in 2019

    Fractional works of Lifepharms (United States) over all fractional works that year. How the balance of science has shifted.

    Other research institutions in New London

    All research institutions in New London

    Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

    Discussion

    Ask a question or share a note about Lifepharms (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.